At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...
A breakthrough study published in npj Aging just introduced a refreshing alternative: a urinary microRNA aging clock. By ...
Discover how artificial intelligence is transforming influenza vaccine development, accelerating timelines and improving ...
Valve’s announcement of the Steam Machine has sparked much debate online about the company’s return to the PC in the living room space, but one key piece of information remains unknown: price. The ...
Monoclonal antibody (mAb) manufacturing must continually improve to keep up with increasing demands. To do this, biomanufacturers can deploy machine learning tools to augment traditional process ...
ANN ARBOR, Mich. – Parents in Ann Arbor are fed up. They want their kids focused on learning -- not glued to their phones. And they’re going to great lengths to make that change happen. Amiel ...
On Monday, Anthropic launched a new frontier model called Claude Sonnet 4.5, which it claims offers state-of-the-art performance on coding benchmarks. The company says Claude Sonnet 4.5 is capable of ...
The power of AI models has long been correlated with their size, with models growing to hundreds of billions or trillions of parameters. But very large models come with obvious trade-offs for ...
Borderlands 4’s Bio-Bulkhead is one of the first bosses you fight in the game and the grappling hook is fundamental to get to the boss. Unlike anything you have faced so far in the game, Bio-Bulkhead ...
FORT ANN — A Long Island man died when the piece of construction machinery he was operating fell into a pond and dragged him below the surface, State Police said. Peter M. McCabe, 62, of Ronkonkoma, ...
Most new renewable energy projects take the form of massive wind or solar farms. Ann Arbor, Michigan, is trying something different: a new city-owned utility is building a local power network within ...
The FDA has accepted Stealth BioTherapeutics’ new drug application for its ultrarare disease candidate, providing a planned decision date of Sept. 26. The timeline is surprising since the agency ...